Tsai, Sun-Lung <br/><br/>
Activation of Th1 immunity is a common immune mechanism for the successful treatment of hepatitis B and C: tetramer assay and therapeutic implications.  [electronic resource] 

 -  Journal of biomedical science   
 - 120-35 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1021-7770 
<br/><br/><label>Standard No.: </label>10.1007/BF02256004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antigens, Viral--immunology<br/>Antiviral Agents--pharmacology<br/>CD8-Positive T-Lymphocytes--immunology<br/>Cytokines--immunology<br/>Epitopes--immunology<br/>Female<br/>Hepatitis B--drug therapy<br/>Hepatitis C--drug therapy<br/>Humans<br/>Immunity, Cellular--drug effects<br/>Lymphocyte Activation--drug effects<br/>Male<br/>Middle Aged<br/>T-Lymphocytes, Cytotoxic--immunology<br/>Th1 Cells--drug effects<br/>Th2 Cells--drug effects